标题 |
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
|
网址 | |
DOI |
10.1016/s1470-2045(18)30765-4
doi
|
其它 |
期刊:Lancet Oncology 作者:Arnaud Scherpereel; Julien Mazières; Laurent Le Corre; Sylvie Lantuéjoul; Pascal Dô; et al 出版日期:2019-02-01 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |